Q4 EPS Estimates for Henry Schein Lowered by William Blair

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Investment analysts at William Blair dropped their Q4 2025 earnings per share estimates for Henry Schein in a research note issued to investors on Monday, May 5th. William Blair analyst B. Vazquez now anticipates that the company will earn $1.22 per share for the quarter, down from their previous forecast of $1.25. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein's Q3 2026 earnings at $1.40 EPS and Q4 2026 earnings at $1.33 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue was down .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 earnings per share.

Other equities research analysts have also issued reports about the stock. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday. Finally, Piper Sandler reduced their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Henry Schein Trading Down 0.3 %

HSIC traded down $0.21 on Wednesday, hitting $68.68. 2,009,912 shares of the company were exchanged, compared to its average volume of 1,633,064. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a fifty day simple moving average of $67.59 and a two-hundred day simple moving average of $71.44. The stock has a market capitalization of $8.41 billion, a PE ratio of 28.26, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HSIC. Invesco Ltd. lifted its holdings in shares of Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after purchasing an additional 17,552 shares in the last quarter. FMR LLC boosted its holdings in shares of Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after acquiring an additional 14,876 shares during the period. Palestra Capital Management LLC purchased a new position in shares of Henry Schein during the fourth quarter valued at approximately $182,988,000. Finally, Fiduciary Management Inc. WI lifted its position in Henry Schein by 7.2% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the period. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.